Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption

被引：3

作者：

Eyal, Nir ^{[1
]}

机构：

[1] Rutgers State Univ, Ctr Populat Level Bioeth, 112 Paterson St, New Brunswick, NJ 08901 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2019年 / 220卷

关键词：

HIV; research ethics; analytic treatment interruption; HIV cure-related studies; clinical trials; human subject research;

D O I：

10.1093/infdis/jiz162

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Only a few of the recommendations made in this supplement are implemented in ongoing HIV remission studies that involve an analytical treatment interruption. The absence of these recommendations in protocols puts sexual partners of study participants at serious risk. This paper addresses one possible barrier to implementation: a certain misunderstanding among sponsors and research entities.

引用

页码：S22 / S23

页数：2

共 5 条

[1]

[Anonymous], RES CURE TRIALS

[2]

[Anonymous], 2011, MOR SCI PROT PART HU

[3] Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention [J].

Dawson, Liza ;

Zwerski, Sheryl .

BIOETHICS, 2015, 29 (05) :316-323

[4] Just compensation: a no-fault proposal for research-related injuries [J].

Henry, Leslie Meltzer ;

Larkin, Megan E. ;

Pike, Elizabeth R. .

JOURNAL OF LAW AND THE BIOSCIENCES, 2015, 2 (03) :645-668

[5]

Resnik David B, 2006, IRB, V28, P1

← 1 →